STOCK TITAN

PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PMV Pharmaceuticals, a precision oncology company, announced that its CEO, David H. Mack, will participate in a Fireside Chat at the Guggenheim Healthcare Talks 2022 Oncology Day on February 9, 2022, at 10:30 am ET. This event will include one-on-one investor meetings, emphasizing PMV's focus on tumor-agnostic therapies targeting p53 mutants. The company is recognized for its groundbreaking work in p53 biology, established by co-founder Dr. Arnold Levine in 1979. For more details, visit PMV Pharma's website.

Positive
  • None.
Negative
  • None.

CRANBURY, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will represent PMV Pharmaceuticals in a “Fireside Chat” at the Guggenheim Healthcare Talks 2022 Oncology Day taking place on February 9, 2022. The company will also participate in one-on-one investor meetings at the conference.

Details on the presentation can be found below.

Guggenheim Healthcare Talks 2022 Oncology Day

Date:Wednesday, February 9, 2022
Time:
10:30 am ET
Format:Fireside Chat

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

For Investors:

Winston Kung
Chief Financial Officer
investors@pmvpharma.com


FAQ

When is PMV Pharmaceuticals participating in the Guggenheim Healthcare Talks 2022 Oncology Day?

PMV Pharmaceuticals will participate in the Guggenheim Healthcare Talks 2022 Oncology Day on February 9, 2022.

What time will PMV Pharmaceuticals' Fireside Chat take place?

The Fireside Chat featuring PMV Pharmaceuticals will take place at 10:30 am ET.

Who will represent PMV Pharmaceuticals at the Guggenheim Healthcare Talks?

David H. Mack, Ph.D., the President & CEO of PMV Pharmaceuticals, will represent the company.

What is the focus of PMV Pharmaceuticals' research?

PMV Pharmaceuticals focuses on developing small molecule, tumor-agnostic therapies targeting p53 mutants.

Where is PMV Pharmaceuticals headquartered?

PMV Pharmaceuticals is headquartered in Cranbury, New Jersey.

PMV Pharmaceuticals, Inc

NASDAQ:PMVP

PMVP Rankings

PMVP Latest News

PMVP Stock Data

76.56M
44.08M
2.3%
80.88%
1.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PRINCETON